Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
International Journal of Academic Medicine and Pharmacy ; 4(5):296-301, 2022.
Article in English | EMBASE | ID: covidwho-2156288

ABSTRACT

Background: The corona virus disease 2019 (COVID-19) caused by SARS-CoV-2 virus has been declared as a global pandemic by WHO. Various hematological parameters may be considered as useful prognostic indicators in COVID-19 infection. Material(s) and Method(s): Age, neutrophil to lymphocyte ratio (NLR), derived-NLR (d-NLR), platelet to lymphocyte ratio (PLR) and red cell distribution width (RDW) of 266 laboratory confirmed COVID-19 patients, at the time of admission, belonging to clinical category B and C were recorded and compared in this single-center, retrospective observational study. The receiver operating characteristic (ROC) curve was applied to determine the thresholds for bio-markers and their prognostic values were assessed. Result(s): A statistically significant elevated NLR (P=0.001), d-NLR ( P=0.001), PLR (P=0.001) and RDW (P=0.026) were noticed in Category C (severe) group when compared to Category B group. From the ROC curve, it was established that d-NLR, NLR and WBC count proved to be a fair distinguisher (area under the curve between 0.7- 0.8) in predicting the clinical severity in COVID-19 patients. NLR and WBC count was found to be having the highest sensitivity of 82%, while d-NLR proved to be highly specific. Elevated age was also significantly associated with illness severity (P=0.001). Conclusion(s): Elevated age, WBC count, NLR, d-NLR, RDW and PLR may be considered as useful prognostic biomarkers for predicting the severity of COVID-19 infection and adverse outcome, with NLR and WBC count showing the highest sensitivity and d-NLR with the highest specificity. Copyright © 2022 Necati Ozpinar. All rights reserved.

SELECTION OF CITATIONS
SEARCH DETAIL